Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric

Journal of Behavioral Addictions

Volumn 3, Issue 3, 2014, Pages 149-156

  Blum, Kenneth ^a,c,d,e,f,g   Febo, Marcelo ^a   Mclaughlin, Thomas ^b   Cronjé, Frans J ^h   David, H A N ⁱ   Gold, Mark S ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Center for Psychiatric Medicine   (United States)

^c Malibu Beach Recovery Center   (United States)

^d PATH Foundation   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f Dominion Diagnostics   (United States)

^g Department of Personalized Medicine IGENE LLC   (United States)

^h STELLENBOSCH UNIVERSITY   (South Africa)

ⁱ UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Dopamine agonist therapy; Dopaminergic; Epigenetics; Neurogenetics; Reward Deficiency Syndrome

Indexed keywords

EID: 84923231198     PISSN: 20625871     EISSN: 20635303     Source Type: Journal    
DOI: 10.1556/JBA.3.2014.019     Document Type: Review

References (106)

1. Al-Eitan, L. N., Jaradat, S. A., Qin, W., Wildenauer, D. M., Wildenauer, D. D., Hulse, G. K. & Tay, G. K. (2012). Characterization of serotonin transporter gene (SLC6A4) polymorphisms and its association with drug dependence in a Jordanian Arab population. Toxicology and Industrial Health, Epub ahead of print.
2. Alsiö, J., Rask-Andersen, M., Chavan, R. A., Olszewski, P. K., Levine, A. S., Fredriksson, R. & Schiöth, H. B. (2014). Exposure to a high-fat high-sugar diet causes strong up-regulation of proopiomelanocortin and differentially affects dopamine D1 and D2 receptor gene expression in the brainstem of rats. Neuroscience Letters, 559, 18-23.
3. Anitha, M., Abraham, P. M. & Paulose, C. S. (2012). Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: Effect of pyridoxine treatment. European Journal of Pharmacology, 696 (1-3), 54-61.
4. Ariza, A. J., Hartman, J., Grodecki, J., Clavier, A., Ghaey, K., Elsner, M., Moore, C., Reina, O. O. & Binns, H. J. (2013). Linking pediatric primary care obesity management to community programs. Journal of Health Care for the Poor and Underserved, 24(2 Suppl), 158-167.
5. Bakermans-Kranenburg, M. J. & van Ijzendoorn, M. H. (2011). Differential susceptibility to rearing environment depending on dopamine-related genes: New evidence and a meta-analysis. Development and Psychopathology, 23 (1), 39-52.
6. Barratt, D. T., Coller, J. K. & Somogyi, A. A. (2006). Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(4), 323-331.
7. Beaver, K. M. & Belsky, J. (2012). Gene-environment interaction and the intergenerational transmission of parenting: Testing the differential-susceptibility hypothesis. Psychiatric Quarterly, 83(1), 29-40.
8. Berridge, K. C. (2000). Measuring hedonic impact in animals and infants: Microstructure of affective taste reactivity patterns. Neuroscience and Biobehavioral Reviews, 24 (2), 173-198.
9. Biswal, B. B., van Kylen, J. & Hyde, J. S. (1997). Simultaneous assessment of flow and BOLD signals in resting-state functional connectivity maps. NMR in Biomedicine, 10 (4-5), 165-170.
10. Blum, K., Bailey, J., Gonzalez, A. M., Oscar-Berman, M., Liu, Y., Giordano, J., Braverman, E. & Gold, M. (2011). Neuro-genetics of reward deficiency syndrome (RDS) as the root cause of "addiction transfer": A new phenomenon common after bariatric surgery. Journal of Genetic Syndromes and Gene Therapy, 2012(1), S2-001.
11. Blum, K., Chen, A. L., Chen, T. J., Rhoades, P., Prihoda, T. J., Downs, B. W., Waite, R. L., Williams, L., Braverman, D., Arcuri, V., Kerner, M., Blum, S. H. & Palomo, T. (2008). LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome. Advances in Therapy, 25(9), 894-913.
12. Blum, K., Chen, A. L., Giordano, J., Borsten, J., Chen, T. J., Hauser, M., Simpatico, T., Femino, J., Braverman, E. R. & Barh, D. (2012). The addictive brain: All roads lead to dopamine. Journal of Psychoactive Drugs, 44 (2), 134-143.
13. Blum, K., Chen, T. J. H., Chen, A. L. C., Rhoades, P., Prihoda, T. J., Downs, B. W., Bagchi, D., Bagchi, M., Blum, S. H., Williams, L., Braverman, E. R., Kerner, M., Waite, R. L., Quirk, B., White, L & Reinking, J. (2008). Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands. Genetic Therapy and Molecular Biology, 12, 129-140.
14. Blum, K., Gardner, E., Oscar-Berman, M. & Gold, M. (2012). "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): Hypothesizing differential responsivity in brain reward circuitry. Current Pharmaceutical Design, 18(1), 113-118.
15. Blum, K., Noble, E. P., Sheridan, P. J., Montgomery, A., Ritchie, T., Jagadeeswaran, P., Nogami, H., Briggs, A. H & Cohn, J. B. (1990). Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA, 263 (15), 2055-2060.
16. Blum, K., Oscar-Berman, M., Badgaiyan, R. D., Palomo, T. & Gold, M. S. (2014). Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. Medical Hypotheses, 82 (5), 606-614.
17. Blum, K., Oscar-Berman, M., Stuller, E., Miller, D., Giordano, J., Morse, S., McCormick, L., Downs, W. B., Waite, R. L., Barh, D., Neal, D., Braverman, E. R., Lohmann, R., Borsten, J., Hauser, M., Han, D., Liu, Y., Helman, M. & Simpatico, T. (2012). Neurogenetics and nutrigenomics of neuro-nutrient therapy for Reward Deficiency Syndrome (RDS): Clinical ramifications as a function of molecular neurobiological mechanisms. Journal of Addiction Research and Therapy, 3(5), 139.
18. Blum, K., Sheridan, P. J., Wood, R. C., Braverman, E. R., Chen, T. J., Cull, J. G. & Comings, D. E. (1996). The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. Journal of the Royal Society of Medicine, 89 (7), 396-400.
19. Brownell, K. D. (2012). Thinking forward: The quicksand of appeasing the food industry. PLoS Medicine, 9 (7), e1001254.
20. Cameron, J. D., Riou, M. E., Tesson, F., Goldfield, G. S., Rabasa-Lhoret, R., Brochu, M. C. & Doucet, È. (2013). The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. Appetite, 60 (1), 111-116.
21. Carpenter, C. L., Wong, A. M., Li, Z., Noble, E. P. & Heber, D. (2013). Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity. Obesity (Silver Spring), 21(9), E467-473.
22. Chen, K. C., Lin, Y. C., Chao, W. C., Chung, H. K., Chi, S. S., Liu, W. S. & Wu, W. T. (2012). Association of genetic polymorphisms of glutamate decarboxylase 2 and the dopamine D2 receptor with obesity in Taiwanese subjects. Annals of Saudi Medicine, 32 (2), 121-126.
23. Chen, P. S., Yang, Y. K., Yeh, T. L., Lee, I. H., Yao, W. J., Chiu, N. T. & Lu, R. B. (2008). Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers - a SPECT study. Neuroimage, 40(1), 275-279.
24. Chen, T. J., Blum, K., Chen, A. L., Bowirrat, A., Downs, W. B., Madigan, M. A., Waite, R. L., Bailey, J. A., Kerner, M., Yeldandi, S., Majmundar, N., Giordano, J., Morse, S., Miller, D., Fornari, F. & Braverman, E. R. (2011). Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: Proposing an addiction candidate gene panel map. Journal of Psychoactive Drugs, 43(2), 108-127.
25. Clarke, T. K., Weiss, A. R., Ferarro, T. N., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O'Brien, C. P., Oslin, D. W., Lohoff, F. W.&Berrettini, W. H. (2014). The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Annals of Human Genetics, 78 (1), 33-39.
26. Colvis, C. M., Pollock, J. D., Goodman, R. H., Impey, S., Dunn, J., Mandel, G., Champagne, F. A., Mayford, M., Korzus, E., Kumar, A., Renthal, W., Theobald, D. E. H. & Nestler, E. J. (2005). Epigenetic mechanisms and gene networks in the nervous system. The Journal of Neuroscience, 25(45), 10379-10389.
27. Connor, J. P., Young, R. M., Lawford, B. R., Ritchie, T. L. & Noble, E. P. (2002). D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence. European Psychiatry, 17 (1), 17-23.
28. Creemers, H. E., Harakeh, Z., Dick, D. M., Meyers, J., Vollebergh, W. A., Ormel, J., Verhulst, F. C. & Huizink, A. C. (2011). DRD2 and DRD4 in relation to regular alcohol and cannabis use among adolescents: Does parenting modify the impact of genetic vulnerability? The TRAILS study. Drug and Alcohol Dependence, 115 (1-2), 35-42.
29. Danilovich, N., Mastrandrea, L. D., Cataldi, L. & Quattrin, T. (2014). Methylphenidate decreases fat and carbohydrate intake in obese teenagers. Obesity (Silver Spring), 22 (3), 781-785.
30. Demetrovics, Z. & Griffiths, M. D. (2012). Behavioral addictions: Past, present and future. Journal of Behavioral Addictions, 1(1), 1-2.
31. Dunn, J. P., Cowan, R. L., Volkow, N. D., Feurer, I. D., Li, R., Williams, D. B., Kessler, R. M & Abumrad, N. N. (2010). Decreased dopamine type 2 receptor availability after bariatric surgery: Preliminary findings. Brain Research, 1350, 123-130.
32. Eisenstein, S. A., Antenor-Dorsey, J. A., Gredysa, D. M., Koller, J. M., Bihun, E. C., Ranck, S. A., Arbeláez, A. M., Klein, S., Perlmutter, J. S., Moerlein, S. M., Black, K. J. & Hershey, T. (2013). A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C] methyl)benperidol. Synapse, 67(11), 748-756.
33. Eny, K. M., Corey, P. N. & El-Sohemy, A. (2009). Dopamine D2 receptor genotype (C957T) and habitual consumption of sugars in a free-living population of men and women. Journal of Nutrigenetics and Nutrigenomics, 2 (4-5), 235-242.
34. Epstein, L. H., Paluch, R. A., Roemmich, J. N. & Beecher, M. D. (2007). Family-based obesity treatment, then and now: Twenty-five years of pediatric obesity treatment. Journal of Health Psychology, 26 (4), 381-391.
35. Epstein, L. H., Temple, J. L., Neaderhiser, B. J., Salis, R. J., Erbe, R. W. & Leddy, J. J. (2007). Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behavioral Neuroscience, 121(5), 877-886.
36. Fang, Y. J., Thomas, G. N., Xu, Z. L., Fang, J. Q., Critchley, J. A. & Tomlinson, B. (2005). An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. International Journal of Cardiology, 102 (1), 111-116.
37. Fuemmeler, B. F., Agurs-Collins, T. D., McClernon, F. J., Kollins, S. H., Kail, M. E., Bergen, A. W. & Ashley-Koch, A. E. (2008). Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring), 16(2), 348-355.
38. Gold, M. S. & Avena, N. M. (2013). Animal models lead the way to further understanding food addiction as well as providing evidence that drugs used successfully in addictions can be successful in treating overeating. Biological Psychiatry, 74(7), e11.
39. Gold, M. S., Blum, K., Oscar-Berman, M. & Braverman, E. R. (2014). Low dopamine function in attention deficit/hyperactivity disorder: Should genotyping signify early diagnosis in children? Postgraduate Medicine, 126 (24393762), 153-177.
40. Grzywacz, A., Kucharska-Mazur, J. & Samochowiec, J. (2008). [Association studies of dopamine D4 receptor gene exon 3 in patients with alcohol dependence]. Psychiatria Polska, 42(3), 453-461. (in Polish)
41. Gyollai, A., Griffiths, M. D., Barta. C., Vereczkei, A., Urban, R., Kun, B., Kokonyei, G., Szekely, A., Sasvari-Szekely, M., Blum, K. & Demetrovics, Z. (2014). The genetics of problem and pathological gambling: A systematic review. Current Pharmaceutical Design, 20 (25), 3993-3999.
42. Hess, M. E., Hess, S., Meyer, K. D., Verhagen, L. A., Koch, L., Brönneke, H. S., Dietrich, M. O., Jordan, S. D., Saletore, Y., Elemento, O., Belgardt, B. F., Franz, T., Horvath, T. L., Rüther, U., Jaffrey, S. R., Kloppenburg, P. & Brüning, J. C. (2013). The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nature Neuroscience, 16(8), 1042-1048.
43. Hettinger, J. A., Liu, X., Hudson, M. L., Lee, A., Cohen, I. L., Michaelis, R. C., Schwartz, C. E., Lewis, S. M. & Holden, J. J. (2012). DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families. Behavioral and Brain Functions, 8, 19.
44. Hone-Blanchet, A. & Fecteau, S. (2014). Overlap of food addiction and substance use disorders definitions: Analysis of animal and human studies. Neuropharmacology, 85C, 81-90.
45. Hou, Q. F. & Li, S. B. (2009). Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neuroscience Letters, 464 (2), 127-130.
46. Huang, X. F., Yu, Y., Zavitsanou, K., Han, M. & Storlien, L. (2005). Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNAin mice prone, or resistant, to chronic high-fat diet-induced obesity. Molecular Brain Research, 135(1-2), 150-161.
47. Huertas, E., Ponce, G., Koeneke, M. A., Poch, C., Espana-Serrano, L., Palomo, T., Jiménez-Arriero, M. A. & Hoenicka, J. (2010). The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming. Genes, Brain and Behavior, 9 (1), 103-109.
48. Jablonski, M. (2011). [Genetic determinants of the alcohol dependence syndrome: Searching for an endophenotype associated with sweet liking in families with alcohol addiction]. Annales Academiae Medicae Stetinensis, 57 (1), 79-87.
49. Jacobs, M. M., Okvist, A., Horvath, M., Keller, E., Bannon, M. J., Morgello, S. & Hurd, Y. L. (2013). Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. Molecular Psychiatry, 18(11), 1205-1210.
50. Jutras-Aswad, D., Jacobs, M. M., Yiannoulos, G., Roussos, P., Bitsios, P., Nomura, Y., Liu, X. & Hurd, Y. L. (2012). Canna-bis- dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: Case-control study. PLoS One, 7(6), e39243.
51. Kessler, R. M., Zald, D. H., Ansari, M. S., Li, R. & Cowan, R. L. (2014). Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity. Synapse, 68(7), 317-320.
52. Lee, S. Y., Wang, T. Y., Chen, S. L., Huang, S. Y., Tzeng, N. S., Chang, Y. H., Wang, C. L., Wang, Y. S., Lee, I. H., Yeh, T. L., Yang, Y. K. & Lu, R. B. (2013). Interaction between novelty seeking and the aldehyde dehydrogenase 2 gene in heroin-dependent patients. Journal of Clinical Psychopharmacology, 33(3), 386-390.
53. Li, C.-Y., Mao, X. & Wei, L. (2008). Genes and (common) pathways underlying drug addiction. PLoS Computational Biology, 4(1).
54. Li, M. D., Ma, J. Z. & Beuten, J. (2004). Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clinical Genetics, 66 (5), 382-392.
55. Lu, H. & Stein, E. A. (2014). Resting state functional connectivity: Its physiological basis and application in neuropharmacology. Neuropharmacology, 84C, 79-89.
56. Masarik, A. S., Conger, R. D., Donnellan, M. B., Stallings, M. C., Martin, M. J., Schofield, T. J., Neppl, T. K., Scaramelly, L. V., Smolen, A. & Widaman, K. F. (2014). For better and for worse: Genes and parenting interact to predict future behavior in romantic relationships. Journal of Family Psychology, 28(3), 357-367.
57. McLaughlin, T., Oscar-Berman, M., Simpatico, T., Giordano, J., Jones, S., Barh, D., Downs, W. B., Waite, R. L., Madigan, M., Dushaj, K., Lohmann, R., Braverman, E. R., Han, D. & Blum, K. (2013). Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic aminoacid therapy (NAAT). Journal of Behavioral Addictions, 2, 117-124.
58. Mills-Koonce, W. R., Propper, C. B., Gariepy, J. L., Blair, C., Garrett-Peters, P. & Cox, M. J. (2007). Bidirectional genetic and environmental influences on mother and child behavior: The family system as the unit of analyses. Development and Psychopathology, 19 (4), 1073-1087.
59. Munafo, M. R., Matheson, I. J. & Flint, J. (2007). Association of the DRD2 gene Taq1A polymorphism and alcoholism: A meta-analysis of case-control studies and evidence of publication bias. Molecular Psychiatry, 12 (5), 454-461.
60. Need, A. C., Ahmadi, K. R., Spector, T. D. & Goldstein, D. B. (2006). Obesity is associated with genetic variants that alter dopamine availability. Annals of Human Genetics, 70(Pt 3), 293-303.
61. Nisoli, E., Brunani, A., Borgomainerio, E., Tonello, C., Dioni, L., Briscini, L., Redaelly, G., Molinary, E., Cavagnini, F. & Carruba, M. O. (2007). D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eating and Weight Disorders, 12 (2), 91-96.
62. Noble, E. P., Gottschalk, L. A., Fallon, J. H., Ritchie, T. L. & Wu, J. C. (1997). D2 dopamine receptor polymorphism and brain regional glucose metabolism. American Journal of Medical Genetics, 74 (2), 162-166.
63. Ohmoto, M., Sakaishi, K., Hama, A., Morita, A., Nomura, M. & Mitsumoto, Y. (2013). Association between dopamine receptor 2 TaqIA polymorphisms and smoking behavior with an influence of ethnicity: A systematic review and meta-analysis update. Nicotine and Tobacco Research, 15 (3), 633-642.
64. Pato, C. N., Macciardi, F., Pato, M. T., Verga, M. & Kennedy, J. L. (1993). Review of the putative association of dopamine D2 receptor and alcoholism: A meta-analysis. American Journal of Medical Genetics, 48 (2), 78-82.
65. Pecina, M., Mickey, B. J., Love, T., Wang, H., Langenecker, S. A., Hodgkinson, C., Shen, P. H., Villafuerte, S., Hsu, D., Weisenbach, S. L., Stohler, C. S., Goldman, D. & Zubieta, J. K. (2013). DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. Cortex, 49(3), 877-890.
66. Pinto, E., Reggers, J., Gorwood, P., Boni, C., Scantamburlo, G., Pitchot, W. & Ansseau, M. (2009). The TaqI A DRD2 polymorphism in type II alcohol dependence: A marker of age at onset or of a familial disease? Alcohol, 43(4), 271-275.
67. Ponce, G., Jimenez-Arriero, M. A., Rubio, G., Hoenicka, J., Ampuero, I., Ramos, J. A. & Palomo, T. (2003). The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. European Psychiatry, 18 (7), 356-360.
68. Roussotte, F. F., Jahanshad, N., Hibar, D. P., Thompson, P. M. & for the Alzheimer's Disease Neuroimaging, I. (2014). Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2). Brain Imaging and Behavior, Epub ahead of print.
69. Savage, S. W., Zald, D. H., Cowan, R. L., Volkow, N. D., Marks-Shulman, P. A., Kessler, R. M., Abumrad, N. N. & Dunn, J. P. (2014). Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity. Obesity (Silver Spring), 22 (6), 1452-1457.
70. Schuck, K., Otten, R., Engels, R. C. & Kleinjan, M. (2014). Initial responses to the first dose of nicotine in novel smokers: The role of exposure to environmental smoking and genetic predisposition. Psychology and Health, 29 (6), 698-716.
71. Shah, N. R. & Braverman, E. R. (2012). Measuring adiposity in patients: The utility of body mass index (BMI), percent body fat, and leptin. PLoS One, 7 (4), e33308.
72. Sikora, M., Gese, A., Czypicki, R., Gasior, M., Tretyn, A., Chojnowski, J., Bieli mski, M., Jaracz, M., Kami mska, A., Junik, R. & Borkowska, A. (2013). Correlations between polymorphisms in genes coding elements of dopaminergic pathways and body mass index in overweight and obese women. Endokrynologia Polska, 64(2), 101-107.
73. Smith, L., Watson, M., Gates, S., Ball, D. & Foxcroft, D. (2008). Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: A HuGE gene-disease association review. American Journal of Epidemiology, 167(2), 125-138.
74. Spangler, R., Wittkowski, K. M., Goddard, N. L., Avena, N. M., Hoebel, B. G. & Leibowitz, S. F. (2004). Opiate-like effects of sugar on gene expression in reward areas of the rat brain. Molecular Brain Research, 124 (2), 134-142.
75. Steele, K. E., Prokopowicz, G. P., Schweitzer, M. A., Magunsuon, T. H., Lidor, A. O., Kuwabawa, H., Kumar, A., Brasic, J. & Wong, D. F. (2010). Alterations of central dopamine receptors before and after gastric bypass surgery. Obesity Surgery, 20(3), 369-374.
76. Stice, E. & Dagher, A. (2010). Genetic variation in dopaminergic reward in humans. Forum of Nutrition, 63, 176-185.
77. Stice, E., Davis, K., Miller, N. P. & Marti, C. N. (2008). Fasting increases risk for onset of binge eating and bulimic pathology: A 5-year prospective study. Journal of Abnormal Psychology, 117(4), 941-946.
78. Stice, E., Spoor, S., Bohon, C. & Small, D. M. (2008). Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science, 322 (5900), 449-452.
79. Stice, E., Spoor, S., Bohon, C., Veldhuizen, M. G. & Small, D. M. (2008). Relation of reward from food intake and anticipated food intake to obesity: A functional magnetic resonance imaging study. Journal of Abnormal Psychology, 117(4), 924-935.
80. Stice, E., Yokum, S., Blum, K. & Bohon, C. (2010). Weight gain is associated with reduced striatal response to palatable food. The Journal of Neuroscience, 30 (39), 13105-13109.
81. Stice, E., Yokum, S., Bohon, C., Marti, N. & Smolen, A. (2010). Reward circuitry responsivity to food predicts future increases in body mass: Moderating effects of DRD2 and DRD4. Neuroimage, 50(4), 1618-1625.
82. Stice, E., Yokum, S., Burger, K., Epstein, L. & Smolen, A. (2012). Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity. The Journal of Neuroscience, 32(29), 10093-10100.
83. Stice, E., Yokum, S., Zald, D. & Dagher, A. (2011). Dopamine-based reward circuitry responsivity, genetics, and overeating. Current Topics in Behavioral Neurosciences, 6, 81-93.
84. Sullivan, D., Pinsonneault, J. K., Papp, A. C., Zhu, H., Lemeshow, S., Mash, D. C. & Sadee, W. (2013). Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: A gene-gene-environment interaction. Translational Psychiatry, 3, doi: 10.1038/tp.2012.146.
85. Suraj Singh, H., Ghosh, P. K. & Saraswathy, K. N. (2013). DRD2 and ANKK1 gene polymorphisms and alcohol dependence: A case-control study among a Mendelian population of East Asian ancestry. Alcohol and Alcoholism, 48 (4), 409-414.
86. Thomsen, G., Ziebell, M., Jensen, P. S., da Cuhna-Bang, S., Knudsen, G. M. & Pinborg, L. H. (2013). No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I. Obesity (Silver Spring), 21 (9), 1803-1806.
87. Tomasi, D. & Volkow, N. D. (2013). Striatocortical pathway dysfunction in addiction and obesity: Differences and similarities. Critical Reviews in Biochemsitry and Molecular Biology, 48(1), 1-19.
88. Trifilieff, P., Feng, B., Urizar, E., Winiger, V., Ward, R. D., Taylor, K. M., Martinez, D., Moore, H., Balsam, P. D., Simpson, E. H. & Javitch, J. A. (2013). Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Molecular Psychiatry, 18 (9), 1025-1033.
89. Tsuchida, H., Nishimura, I. & Fukui, K. (2012). [Alcohol and substance dependence]. Brain Nerve, 64(2), 163-173. (in Japanese)
90. Valomon, A., Holst, S. C., Bachmann, V., Viola, A. U., Schmidt, C., Zürcher, J., Berger, W., Cajochen, C. & Landolt, H. P. (2014). Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults. Chronobiology International, 31 (5), 705-714.
91. Vaske, J., Makarios, M., Boisvert, D., Beaver, K. M. & Wright, J. P. (2009). The interaction of DRD2 and violent victimization on depression: An analysis by gender and race. Journal of Affective Disorders, 112 (1-3), 120-125.
92. Vereczkei, A., Demetrovics, Z., Szekely, A., Sarkozy, P., Antal, P., Szilagyi, A., Sasvari-Szekely, M. & Barta, C. (2013). Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS One, 8(6), e66592.
93. Volkow, N. D., Wang, G. J., Telang, F., Fowler, J. S., Goldstein, R. Z., Alia-Klein, N., Logan, J., Wong, C., Thanos, P. K., Ma, Y. & Pradhan, K. (2009). Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring), 17(1), 60-65.
94. Wang, D., Li, Y., Lee, S. G., Wang, L., Fan, J., Zhang, G., Wu, J., Ju, Y. & Li, S. (2011). Ethnic differences in body composition and obesity related risk factors: Study in Chinese and white males living in China. PLoS One, 6 (5), e19835.
95. Wang, F., Simen, A., Arias, A., Lu, Q. W. & Zhang, H. (2013). A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Human Genetics, 132(3), 347-358.
96. Wang, L., Liu, X., Luo, X., Zeng, M., Zuo, L. & Wang, K. S. (2013). Genetic variants in the fat mass- and obesity-associated (FTO) gene are associated with alcohol dependence. Journal of Molecular Neuroscience, 51 (2), 416-424.
97. Wang, T. Y., Lee, S. Y., Chen, S. L., Huang, S. Y., Chang, Y. H., Tzeng, N. S., Wang, C. L., Hui Lee, I., Yeh, T. L., Yang, Y. K. & Lu, R. B. (2013). Association between DRD2, 5-HTTLPR, and ALDH2 genes and specific personality traits in alcoholand opiate-dependent patients. Behavioral Brain Research, 250, 285-292.
98. Whitmer, A. J. & Gotlib, I. H. (2012). Depressive rumination and the C957T polymorphism of the DRD2 gene. Cognitive, Affective & Behavioral Neuroscience, 12 (4), 741-747.
99. Willuhn, I., Burgeno, L. M., Groblewski, P. A. & Phillips, P. E. (2014). Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nature Neuroscience, 17(5), 704-709.
100. Winkler, J. K., Woehning, A., Schultz, J. H., Brune, M., Beaton, N., Challa, T. D., Minkova, S., Roeder, E., Nawroth, P. P., Friederich, H. C., Wolfrum, C. & Rudofsky, G. (2012). TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. Nutrition, 28(10), 996-1001.
101. Xu, K., Lichtermann, D., Lipsky, R. H., Franke, P., Liu, X., Hu, Y., Cao, L., Schwab, S. G., Wildenauer, D. B., Bau, C. H., Ferro, E., Astor, W., Finch, T., Terry, J., Taubman, J., Maier, W. & Goldman, D. (2004). Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Archives of General Psychiatry, 61(6), 597-606.
102. Young, R. M., Lawford, B. R., Nutting, A. & Noble, E. P. (2004). Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. Addictive Behaviors, 29 (7), 1275-1294.
103. Zai, C. C., Ehtesham, S., Choi, E., Nowrouzi, B., de Luca, V., Stankovich, L., Davidge, K., Freeman, N., King, N., Kennedy, J. L. & Beitchman, J. H. (2012). Dopaminergic system genes in childhood aggression: Possible role for DRD2. The World Journal of Biological Psychiatry, 13 (1), 65-74.
104. Zhang, L., Hu, L., Li, X., Zhang, J. & Chen, B. (2014). The DRD2 rs1800497 polymorphism increase the risk of mood disorder: Evidence from an update meta-analysis. Journal of Affective Disorders, 158, 71-77.
105. Zhu, Q. & Shih, J. C. (1997). An extensive repeat structure down-regulates human monoamine oxidase A promoter activity independent of an initiator-like sequence. Journal of Neurochemistry, 69(4), 1368-1373.
106. Zou, Y. F., Wang, F., Feng, X. L., Li, W. F., Tian, Y. H., Tao, J. H., Pan, F. M. & Huang, F. (2012). Association of DRD2 gene polymorphisms with mood disorders: A meta-analysis. Journal of Affective Disorders, 136 (3), 229-237.